FluoGuide A/S stock | 2026 rating, price & analyst opinions

FluoGuide A/S

OM:FLUO

kr 35,80

kr-0,20 (-0,56%)

35,80 kr

kr-0,20 (-0,56%)

End-of-day quote: 04/09/2026

FluoGuide A/S Stock Value

The current analyst recommendation for OM:FLUO is: sf_No Opinion.

sf_No Opinion

FluoGuide A/S Company Info

EPS Growth 5Y

-5,26%

Market Cap

kr0,59 B

Long-Term Debt

kr0,04 B

Quarterly earnings

05/27/2026

Dividend

kr0,00

Dividend Yield

0,00%

Founded

2018

Industry

Health Care

Country

Denmark

Website

FluoGuide A/S

ISIN Number

DK0061123312

Website

http://fluoguide.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr74,06

106.87%

Last Update: 04/10/2026

Analysts: 1

Highest Price Target kr74,06

Average Price Target kr74,06

Lowest Price Target kr74,06

In the last five quarters, FluoGuide A/S’s Price Target has fallen from kr158,30 to kr91,18 - a -42,40% decrease. One analysts predict that FluoGuide A/S’s share price will increase in the coming year, reaching kr74,06. This would represent an increase of 106,87%.

Top growth stocks in the health care sector (5Y.)

What does FluoGuide A/S do?

FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent. The company specializes in precision surgery, utilizing advanced imaging techniques to enhance the accuracy of tumor resections. The company aims to develop and commercialize its proprietary products that facilitate better visualization of cancerous tissues during surgical procedures. Business Segments The company operates primarily in the life sciences sector,...

Business Segments

The company operates primarily in the life sciences sector, concentrating on the development of imaging and surgical guidance solutions. The company’s key business segment involves the research and development of its proprietary technology, which integrates fluorescent imaging to assist surgeons in real-time during operations. The company’s technology is designed to provide enhanced visualization of tumors, thereby improving the precision of surgical interventions.

Additionally, the company engages in extensive clinical trials to validate its products and gather necessary regulatory approvals.

Business Strategy

The company’s business strategy focuses on establishing itself as a leader in the field of precision surgery through continuous innovation and strategic partnerships. The company aims to advance its proprietary technology by investing in research and development to enhance its product offerings. By prioritizing clinical validation and regulatory compliance, the company seeks to ensure that its products meet the highest standards of safety and efficacy.

The company also intends to expand its market presence by forming alliances with key stakeholders in the healthcare sector, including hospitals, surgical centers, and medical device distributors. This collaborative approach is expected to facilitate the adoption of its technologies and drive growth.

Furthermore, the company is committed to educating healthcare professionals about the benefits of its solutions, thereby fostering a strong demand for its products.

Products and Services

The company offers a range of innovative products designed to enhance surgical procedures, particularly in oncology. The company’s primary product line includes advanced imaging systems that utilize fluorescent markers to improve tumor visualization during surgery. These products are intended to assist surgeons in accurately identifying cancerous tissues, thereby facilitating complete tumor resections while minimizing damage to surrounding healthy tissues.

The company also focuses on developing complementary services that support the use of its imaging technologies, including training programs for medical professionals and technical support during surgical procedures.

Geographical Markets Served

The company primarily serves markets in Europe, where it is actively engages in clinical trials and product development. The company focuses on establishing a strong presence in key European countries, leveraging the region's advanced healthcare infrastructure and regulatory frameworks. Additionally, the company is exploring opportunities to expand its reach into North America and other international markets as it progresses through regulatory approvals.

Customers

The company serves a diverse range of customers within the healthcare sector, including hospitals, surgical centers, and medical professionals specializing in oncology. The company’s customer base comprises surgeons and healthcare providers who utilize its imaging technologies to enhance surgical outcomes for cancer patients.

Sales and Marketing

The company employs a targeted sales and marketing strategy to promote its innovative surgical technologies. The company utilizes a combination of direct sales, partnerships with medical device distributors, and participation in industry conferences to reach potential customers.

The company emphasizes education and training as key components of its marketing efforts, ensuring that healthcare professionals are well-informed about the benefits and applications of its products. The company’s marketing approach is designed to build awareness and drive demand for its technologies in the surgical community.

Government Regulations

The company is committed to compliance with all applicable regulations, including those set forth by the European Medicines Agency (EMA) and other relevant authorities.

History

FluoGuide A/S was founded in 2018. The company was incorporated in 2018.

New support ticket

Explore

FluoGuide A/S Stock Value

FluoGuide A/S Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does FluoGuide A/S do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

FluoGuide A/S Stock Value

FluoGuide A/S Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does FluoGuide A/S do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.